ESCMID Global 2025
04.11.25 - 04.15.25 12:00 AM
04.11.25 - 04.15.25 12:00 AM
ESCMID Global 2025 provides healthcare professionals with the latest insights into infectious diseases and clinical microbiology.
Emerging antimicrobial resistance (AMR) is rising, claiming more than 700,000 lives across the world every year. Antibiotic susceptibility testing plays a crucial role in the patient treatment journey.
Discover how our Diagnostics businesses, Beckman Coulter Diagnostics and Cepheid are accelerating innovation to improve antimicrobial therapy decisions for every patient.
Together, we are focused on solving complex health challenges for patients around the world, enabling healthcare providers to diagnose diseases with unprecedented speed and precision.
Visit our Diagnostics businesses at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in Booth E10 to learn more.